ArticleFrontiers in medicine2026
Effect of acupuncture on asthma control and body weight changes in obese patients with asthma.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic persistent asthma is difficult to control and is often comorbid with obesity. Acupuncture has been shown to reduce airway inflammation and improve lung function, and it may also help regulate body weight to some extent. Currently, obesity combined with chronic persistent asthma is a research hotspot, but interventional studies involving acupuncture remain relatively limited. This study aims to fill this gap. Methods: Patients were divided into a control group (conventional western medical treatment) and a treatment group (conventional western medical treatment plus acupuncture). Baseline characteristics between the two groups were compared using univariate analysis. Changes before and after treatment were assessed for pulmonary function indicators (PEF, FEV1, FEV1/FVC), Asthma Control Test (ACT) scores, Asthma Quality of Life Questionnaire (AQLQ) scores, serum inflammatory markers (IL-17, CRP), and BMI. Multivariate logistic regression and multiple linear regression analyses were conducted to evaluate the effects of treatment modality on asthma control and body weight changes. A response model was constructed to predict asthma control outcomes, and its performance was evaluated using the ROC curve. Further stratified analyses were performed to assess the predictive ability of the model in different subgroups. Results: After treatment, the treatment group showed improvements in pulmonary function, asthma control, quality of life, inflammatory markers, and BMI. Treatment modality was independently associated with asthma control and weight changes. Asthma severity, comorbidities, baseline FEV1, and baseline CRP levels were also associated with asthma control. The response model demonstrated moderate discriminative ability (AUC = 0.656), with stronger effects observed in patients aged ≥50 years, males, and those without acute exacerbations in the past year. Conclusion: This study provides a new intervention strategy and supporting evidence for individualized treatment in obese patients with chronic persistent asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.